Holen Sie sich die Stockscreener-App
8.21
8.60%
0.65
Handel nachbörslich:
8.05
-0.16
-1.95%
Schlusskurs vom Vortag:
$7.56
Offen:
$7.54
24-Stunden-Volumen:
105.45K
Relative Volume:
0.50
Marktkapitalisierung:
$769.75M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
87.81
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
+16.95%
1M Leistung:
+9.61%
6M Leistung:
-30.31%
1J Leistung:
-21.06%
1-Tages-Spanne:
$7.4069
$8.225
1-Wochen-Bereich:
$6.62
$8.225
52-Wochen-Spanne:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(619) 949-3681
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
8.21 | 640.94M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
Is Gyre Therapeutics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Summary & Weekly High Potential Alerts - Newser
How to build a custom watchlist for Gyre Therapeutics Inc.July 2025 Highlights & Real-Time Volume Analysis - Newser
US Undiscovered Gems 3 Promising Small Caps with Strong Potential - simplywall.st
Tools to assess Gyre Therapeutics Inc.’s risk profileDividend Hike & Smart Money Movement Alerts - Newser
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down on Disappointing Earnings - Defense World
Price momentum metrics for Gyre Therapeutics Inc. explained2025 Price Momentum & Low Risk Entry Point Guides - Newser
Gyre Therapeutics Inc. stock trend outlook and recovery pathWatchlist Summary for Active Day Traders - Newser
Using AI based signals to follow Gyre Therapeutics Inc.Expert-Backed High Yield Stock Watchlist - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Using RSI to spot recovery in Gyre Therapeutics Inc.Long-Term Allocation Strategy Summary Breakdown - Newser
Gyre Therapeutics Reports Q2 2025 Earnings and Strategic Updates - TipRanks
Gyre Therapeutics Misses Estimates And Swaps In A New CEO - Finimize
GYRE THERAPEUTICS, INC. SEC 10-Q Report - TradingView
Can you recover from losses in Gyre Therapeutics Inc.Free Reliable Investment Entry Point Signals - Newser
Gyre Therapeutics' Q2 revenue misses estimates - MarketScreener
Gyre Therapeutics Hits Major Milestone: Phase 3 Liver Drug Success Powers $128M Revenue Outlook - Stock Titan
Sector Rotation Brings Gyre Therapeutics Inc. Into FocusTriple Return Setup With Risk Control Explained - beatles.ru
Published on: 2025-08-11 05:27:12 - Newser
Understanding Gyre Therapeutics Inc.’s price movementFree Trade Setups With AI Powered Filters - Newser
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionReal-Time Entry Signals for Top Stocks - Newser
Published on: 2025-08-10 23:59:25 - Newser
What makes Gyre Therapeutics Inc. stock price move sharplyWeekly Market Direction and Sector Summary - Newser
When is the best time to exit Gyre Therapeutics Inc.Free Fundamental Growth Stock Analysis - Newser
How to use a screener to detect Gyre Therapeutics Inc. breakoutsInsider Strategy for High Conviction Picks - Newser
Gyre Therapeutics (GYRE) Projected to Post Earnings on Tuesday - Defense World
Candlestick signals on Gyre Therapeutics Inc. stock todayTrend Confirmation Scanner with Entry Focus - Newser
Regression analysis insights on Gyre Therapeutics Inc. performanceHigh Accuracy Trade Setup Identification - Newser
Bank of New York Mellon Corp Buys 2,596 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Earnings visualization tools for Gyre Therapeutics Inc.Weekly Outlook for Short Term Investors - Newser
How hedge fund analytics apply to Gyre Therapeutics Inc. stockEntry Timing Tracker with Alert Accuracy - Newser
How institutional ownership impacts Gyre Therapeutics Inc. stockEquity Portfolio Outlook and Performance Summary - Newser
Gyre Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Daily Top Performing Stock Insights - Newser
Using flow based indicators on Gyre Therapeutics Inc.AI Generated Momentum Stock Forecast Guide - Newser
Gyre Therapeutics Inc. Breakout Confirmed by Volume MetricsStock Market Entry Timing Signals Revealed - metal.it
Should I hold or sell Gyre Therapeutics Inc. stock in 2025Get insider insights into market trends - Jammu Links News
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
| Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
| Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
| Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
| Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
| Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
| Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
| Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
| Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
| Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):